Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
Polyglutamine (polyQ) ataxias are a heterogenous group of neurological disorders all caused by an expanded CAG trinucleotide repeat located in the coding region of each unique causative gene. To date, polyQ ataxias encompass six disorders: spinocerebellar ataxia types 1, 2, 3, 6, 7, and 17 and accou...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a2ca7d2f150f42ffa71be3091986a353 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|